Patents

US 12410133 B2: Crystalline (r)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)piperazine-1-carboxylate, compositions and methods of use thereof

Granted
2025-09-09
Filed
2023-05-05 application 18143765
Type
Utility · 16 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Provided herein are crystalline forms of (R)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)piperazine-1-carboxylate. Pharmaceutical compositions comprising crystalline forms of (R)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)piperazine-1-carboxylate are also disclosed.

Source: PVGPATDIS, file of 2026-04-10 (ipg250909.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Celgene Corporation 413 patentsUS company or organizationSummit, NJPVGPATDIS, file of 2026-04-10
Lundbeck La Jolla Research Center, Inc. 12 patentsUS company or organizationSan Diego, CAPVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Lianfeng HuangJalan Pedongkelan, NJ33PVGPATDIS, file of 2026-04-10
Nancy TsouEdison, NJ4PVGPATDIS, file of 2026-04-10
Nicole S. WhiteSan Diego, CA9PVGPATDIS, file of 2026-04-10
Jun XuSuzhou, CN46PVGPATDIS, file of 2026-04-10
Qun ZhangSuzhou, CN14PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C07DHeterocyclic compoundsC07D211/94PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P35/00PVGPATDIS, file of 2026-04-10
C07BGeneral methods of organic chemistry; apparatus thereforC07B2200/13PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2025-04-11Assignment
Assignment of assignor's interest
TSOU, NANCY signed 2019-05-08
HUANG, LIANFENG signed 2019-05-16
CELGENE CORPORATION SUMMIT, NJ70824/584ECORSEXC, file of 2026-09-25
2025-04-11Assignment
Assignment of assignor's interest
WHITE, NICOLE SUZANNE signed 2019-04-30ABIDE THERAPEUTICS, INC. SAN DIEGO, CA70824/581ECORSEXC, file of 2026-09-25
2025-04-11Merger
Merger
ABIDE THERAPEUTICS, INC. signed 2019-05-28LUNDBECK LA JOLLA RESEARCH CENTER, INC. SAN DIEGO, CA70815/756ECORSEXC, file of 2026-09-25
2025-04-11Assignment
Assignment of assignor's interest
CRYSTAL PHARMATECH CO., LTD signed 2019-04-29ABIDE THERAPEUTICS, INC. SAN DIEGO, CA70815/673ECORSEXC, file of 2026-09-25
2025-04-11Assignment
Assignment of assignor's interest
XU, JUN signed 2019-04-30
ZHANG, QUN signed 2019-04-30
CRYSTAL PHARMATECH CO., LTD SUZHOU70815/657ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.